“Β-CARYOPHYLLENE AS A PARTNER FOR DOXORUBICIN: EVIDENCE FOR CHEMOSENSITISATION, TISSUE PROTECTION AND LIPID-BASED CO-DELIVERY”. Frontier in Medical and Health Research 4, no. 3 (March 31, 2026): 4636–4645. Accessed November 9, 2026. https://fmhr.net/index.php/fmhr/article/view/3855.